We are monitoring the impact of COVID-19 on APAC Consumer Healthcare Market Get in touch with us for detailed analysis Know More
Pulished Date August, 2021
ID: 12041
Share on
Share on

Asia-Pacific Consumer Healthcare Market Research Report – Segmented By Product, Distribution Network & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2021 to 2026)

Pulished: August, 2021
ID: 12041
Pages: 100

APAC Consumer Healthcare Market Size (2021 to 2026)

The size of the APAC consumer healthcare market is forecasted to be growing at a notable CAGR during the forecast period.

The major factors contributing to the growth of the APAC consumer healthcare market include high demand for self-medication, rising healthcare costs, increasing geriatric population, which is more prone to disease, deterioration of mental health, and the shift from prescription-to-prescription drugs and over counter products. In addition, the approval of preventive medicine and wellness and the increase in disposable income further drive the market's growth.

Medical tourism increases the influx, the lucrative activity of day surgery with less investment and more profits, the increase of specialized hospitals, the increase in private health insurance coverage, and the updating of IT and healthcare operations tend to drive the APAC healthcare market. In addition, the transformation of pharmacies with e-commerce, investments by major players, the launch of telecommunications for home health platforms, stricter regulations in favor of consumers, and the increase in mergers and acquisitions in the health sector are factors responsible for the growth of the health sector in the APAC region.

The increase in chronic and non-communicable diseases (NCDs) tends to put pressure on the extensive health system in the APAC region. According to the World Economic Forum, by 2030, cardiovascular disease (CVD), chronic respiratory disease, cancer, diabetes, and mental illness will cost the global economy $ 48 trillion. Therefore, the development and accelerated use of online sources and the growing demand for branded, private label, and generic OTC products will provide many opportunities in the near future.

However, several strict government regulations and the presence of many counterfeit pharmaceuticals companies restraints the market. In addition to this, limited financial resources, diverse consumer segments creating complexities, an underdeveloped medical infrastructure, inconsistent reimbursement regimes, intense competition from major players in adjacent industries (high-tech and consumer electronics), and regional startups hamper the market growth.

Impact of COVID-19 on the APAC Consumer Healthcare Market:

The APAC consumer healthcare market is expected to experience a significant rebound in growth in 2021, after seeing overall sales slowed significantly by the COVID-19 lockdown. The recovery in market performance will be driven by the resurgence of longer-term trends supported by the general increase in consumer health awareness, especially in Asian countries.

This research report on the APAC consumer healthcare market has been segmented and sub-segmented into the following categories.

By Product:

  • OTC Pharmaceuticals
  • Dietary Supplements

By Distribution Network:

  • Departmental Stores
  • Independent Retailers
  • Pharmacies or Drugstores
  • Specialist Retailers
  • Supermarkets or Hypermarkets

By Country:

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Geographically, Health expenditure for APAC countries was USD 210 billion in 2017. Indonesia's total health expenditure was USD 28 billion and is expected to grow at a CAGR of 7.9% by 2030. Singapore is the fourth-best health infrastructure globally, with less than 5% of GDP spend on health care and provides multiple levels of care to each resident.

With strong economic growth in the APAC region comes benefits and challenges for the health sector. Despite the increase in hospitals, patients in both rural and urban areas still face accessibility and affordability challenges. Technological innovation solves the challenges of digital activation; for example, Sustainable Healthcare Solutions (SHS) from GE Healthcare develop clinically and economically relevant technologies, providing professional training for medical staff and solutions for financial help to companies.

Inequalities in the Philippines affect the healthcare sector, enabling Hospital Management Asia to provide specific solutions for digitizing and improving information communication in healthcare, telemedicine, and business development. The Philippines accounts for about 48% of direct medical expenditure. However, prescription drugs continue to dominate the market. With laws such as the Cheapest Medicines Act of 2008 and the Universal Health Care Act of 2013 that stimulate the growth potential of the generic drug market, 5 in 10 Filipinos use generic drugs.

To reduce the costs of pharmaceuticals, the Japanese government is implementing policies to expand the use of generic drugs, thus helping the APAC consumer healthcare market in upcoming years.


Companies such as Johnson & Johnson, Boehringer Ingelheim GmbH, GlaxoSmithKline plc, Amway, Bayer AG, Pfizer Inc., Abbott Laboratories, Sanofi, BASF SE, DSM, American Health, Herbalife, The Himalaya Drug Company, Kellogg, Takeda Pharmaceuticals, and Teva Pharmaceuticals are some of the leading companies in the APAC consumer healthcare market profiled in this report.

  1. Introduction                                                          
    1. Market Definition                                               
    2. Scope of the report                                            
    3. Study Assumptions
    4. Base Currency, Base Year and Forecast Periods
  2. Research Methodology
    1. Analysis Design
    2. Research Phases
      1. Secondary Research
      2. Primary Research
      3. Data Modelling
      4. Expert Validation
    3. Study Timeline
  3. Report Overview
    1. Executive Summary
    2. Key Inferences
  4. Market Dynamics
    1. Impact Analysis
      1. Drivers
      2. Restraints
      3. Opportunities
    2. Regulatory Environment
    3. Technology Timeline & Recent Trends
  5. Competitor Benchmarking Analysis
    1. Key Player Benchmarking
      1. Market share analysis
      2. Products/Service
      3. Regional Presence
    2. Mergers & Acquisition Landscape
    3. Joint Ventures & Collaborations
  6. Market Segmentation
    1. Consumer Healthcare Market, By Product
      1. OTC Pharmaceuticals
      2. Dietary Supplements
      3. Market Size Estimations & Forecasts (2021-2026)
      4. Y-o-Y Growth Rate Analysis
      5. Market Attractiveness Index
    2. Consumer Healthcare Market, By Distribution Network
      1. Departmental Stores
      2. Independent Retailers
      3. Pharmacies or Drugstores
      4. Specialist Retailers
      5. Supermarkets or Hypermarkets
      6. Market Size Estimations & Forecasts (2021-2026)
      7. Y-o-Y Growth Rate Analysis
      8. Market Attractiveness Index
  7. Geographical Landscape
    1. Consumer Healthcare Market, by Region
    2. APAC - Market Analysis (2021 to 2026)
      1. By Country
        1. India
        2. China
        3. Japan
        4. ANZ
        5. South Korea
        6. Rest of APAC
  8. Key Player Analysis
    1. Johnson & Johnson
      1. Business Description
      2. Products/Service
      3. Financials                             
      4. SWOT Analysis
      5. Recent Developments
      6. Analyst Overview
    2. Boehringer Ingelheim GmbH
    3. GlaxoSmithKline plc
    4. Amway
    5. Bayer AG
    6. Pfizer Inc.
    7. Abbott Laboratories
    8. Sanofi
    9. Teva Pharmaceutical Industries Ltd.
    10. BASF SE
    11. DSM
    12. American Health
    13. Herbalife
    14. The Himalaya Drug Company
    15. Kellogg
    16. Takeda Pharmaceuticals
  9. Market Outlook & Investment Opportunities
  10. Appendix                                               
    1. List of Tables
    2. List of Figures
  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.
  • Segment-level analysis in terms of product and distribution network along with market size forecasts and estimations to detect key areas of industry growth in detail.
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics.
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis.
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development.
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment.
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies.
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions.
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market.
  1. Asia Pacific Consumer Healthcare Market, By Product, From 2021 to 2026 (USD Billion)
  2. Asia Pacific OTC Pharmaceuticals Market, By Region, From 2021 to 2026 (USD Billion)
  3. Asia Pacific Dietary Supplements Market, By Region, From 2021 to 2026 (USD Billion)
  4. Asia Pacific Consumer Healthcare Market, By Distribution Network, From 2021 to 2026 (USD Billion)
  5. Asia Pacific Departmental Stores Market, By Region, From 2021 to 2026 (USD Billion)
  6. Asia Pacific Independent Retailers Market, By Region, From 2021 to 2026 (USD Billion)
  7. Asia Pacific Pharmacies or Drugstores Market, By Region, From 2021 to 2026 (USD Billion)
  8. Asia Pacific Specialist Retailers Market, By Region, From 2021 to 2026 (USD Billion)
  9. Asia Pacific Supermarkets or Hypermarkets Market, By Region, From 2021 to 2026 (USD Billion)
  10. Japan Consumer Healthcare Market, By Product, From 2021 to 2026 (USD Billion)
  11. Japan Consumer Healthcare Market, By Distribution Network, From 2021 to 2026 (USD Billion)
  12. China Consumer Healthcare Market, By Product, From 2021 to 2026 (USD Billion)
  13. China Consumer Healthcare Market, By Distribution Network, From 2021 to 2026 (USD Billion)
  14. India Consumer Healthcare Market, By Product, From 2021 to 2026 (USD Billion)
  15. India Consumer Healthcare Market, By Distribution Network, From 2021 to 2026 (USD Billion)
  16. Australia Consumer Healthcare Market, By Product, From 2021 to 2026 (USD Billion)
  17. Australia Consumer Healthcare Market, By Distribution Network, From 2021 to 2026 (USD Billion)
  18. South Korea Consumer Healthcare Market, By Product, From 2021 to 2026 (USD Billion)
  19. South Korea Consumer Healthcare Market, By Distribution Network, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports


$ 1234 3335

Click for Request Sample